Hydroxyacetophenone

Name: CAS 99-93-4 Daily Chemical 4-Hydroxyacetophenone/P-Hydroxyacetophenone/Hydroxyacetophenone
Brand: Xi'an LY Health Technology Co., Ltd
SKU: 2276488155

Shaanxi, ChinaXi'an LY Health Technology Co., Ltd

US$19.00-30.00

1 kg

Product profile

Customization

Available

CAS No.

99-93-4

Formula

C8h8o2

Model NO.

LYJK-Hydroxyacetophenone

EINECS

202-802-8

Type

Synthesis Material Intermediates

Appearance

Powder

Quality

Refined

Colour

White

Other Names

Hydroxyacetophenone

Selling Units

Single Item

Product Name

4-Hydroxyacetophenone

Source

Synthetic

Gross Weight Per

1.200 Kg Batch

Function

Used for Cosmetic

Test Method

HPLC

Einecs No.

202-802-8

Package Size Per

Batch 40X20X15cm

Normal Package

25kg/Drum

Mf

C8h8o2

Shelf Life

2years

Application

Cosmetic Industries

Transport Package

as Your Request

Specification

Cosmetic grade

Trademark

LYHealth

Origin

Shaanxi, China

Company profile

High Repeat Buyers ChoiceFast Delivery100% Finished Products InspectionQuality Assurance

Xi'an LY Health Technology Co., Ltd

Shaanxi, China

Business Type: Manufacturer/Factory CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 5 Years CertifiedNearest Port: Beijing Port; Qingdao Port; Shanghai PortAverage Response Time: ≤7.30h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryXi'an LY Health Technology Co., Ltd. is a China-based trading company established in 2021 with six employees. Its stated product scope includes plant extracts, pharmaceutical intermediates, health supplements, cosmetic raw materials, and veterinary raw materials. The supplier reports that 90% of total sales are exports and that it has exported for five years. It offers several forms of customization, but its R&D resources are limited: one engineer, no patents, no new products in the past year, no SDK, and no available design documentation for audit. The supplier does not provide ODM services or OEM services for popular brands. Service-management controls are weak or undocumented, and no overseas warehouse, showroom, agent or branch, or offline trade-show experience is reported. The provided information does not establish certifications, production facilities, customer cases, or verified financial strength.

Supplier typeThe supplier is identified as a limited company and specifically classified as a trading company, with six employees and a product portfolio covering plant extracts, pharmaceutical intermediates, health supplements, cosmetic raw materials, and veterinary raw materials. This indicates an intermediary or trading-oriented business model rather than confirmed in-house manufacturing.

After-Sales capabilityThe supplier has not provided written procedures or records for handling customer complaints, corrective and preventive actions, or effective supplier-service assessment. It also reports no overseas warehouse, showroom, overseas agent or branch, and no offline trade-show participation, indicating limited documented after-sales and overseas support infrastructure.

R&D capabilityInnovation evidence is weak: the supplier reports no new products in the past year, no available SDK, one R&D engineer, zero patents, and no design input, output, review, verification, or validation documentation available for audit. These stated limitations indicate a deficiency in demonstrated R&D and innovation capability.

Customization capabilityThe supplier explicitly reports customization from designs, samples, full customization, minor customization, and flexible customization, with an R&D engineer responsible for providing samples according to customer requirements. However, the absence of R&D documentation and the single-engineer team limits verification of the depth and scalability of this capability.